LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Tissue of Origin Test Determines Primary Tumor Site

A study was performed to examine the diagnostic performance of the tissue of origin test using metastatic cancer of unknown origin specimens. More...
10 Nov 2008

Controls for Warfarin and Thrombophilia Introduced

A genetic controls business was launched with the introduction of controls for testing warfarin sensitivity and controls for thrombophilia testing. More...
04 Nov 2008

Newly Discovered Genome Variations Predispose to BCC

Common versions of two single-letter variations in the human genome, single nucleotide polymorphisms, confer risk of basal cell carcinoma, the most common cancer among people of European ancestry. More...
29 Oct 2008

Screening Method Detects Chromosomal Abnormalities Associated with Autism

Multiplex ligation-dependent probe amplification, a recently developed method of investigating DNA, was evaluated as a screen for chromosomal disorders commonly associated with autism spectrum disorders. More...
29 Oct 2008

Response to Lyme Disease Determined by Individual's Genetic Makeup

Lyme disease can have dramatically different outcomes in different people. More...
27 Oct 2008

MTS Health Investors Purchases DNA Diagnostics Center

MTS Health Investors has purchased DNA Diagnostics Center, Inc. and related entities. Terms of the transaction were not disclosed. More...
27 Oct 2008

Mapping Human Proteins Will Help Identify Diseases

Swedish scientists are creating an atlas of the proteins in the human's body tissues and cells. More...
27 Oct 2008
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Thyroid Test
Anti-Thyroid EIA Test


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
ADLM